Top compounds associated with response to VLDLR


Feature Type Standardized
Nominal ANOVA
mRNA KPT185 CTRPv2 pan-cancer AAC 0.00036 1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0002 1
mRNA BEC CTRPv2 pan-cancer AAC 0.00032 1
mRNA SB 505124 GDSC1000 pan-cancer AAC 0.00015 1
mRNA EX-527 CTRPv2 pan-cancer AAC -8.5e-05 1
mRNA C6-ceramide CTRPv2 pan-cancer AAC -6.8e-05 1
Download CSV